Research Overview
What a matrikine is
Matrikines are peptide fragments released when extracellular matrix proteins are degraded, and which then act as signals back onto the cells that built the matrix. The concept is what gives this class its research interest: a fibroblast can read fragments of its own surroundings as information about turnover. Synthetic matrikines reproduce those fragments deliberately, and the palmitoyl modification is a formulation strategy layered on top of the biology rather than part of it.
The two peptides in this serum
- Palmitoyl tripeptide-1 (Pal-GHK) — the lipidated form of glycyl-histidyl-lysine, studied in fibroblast cultures for effects on collagen and glycosaminoglycan synthesis. Unlike GHK-Cu it is supplied without a coordinated copper ion, so copper-dependent chemistry does not apply.
- Palmitoyl tetrapeptide-7 (Pal-GQPR) — derived from an immunoglobulin G sequence and examined in dermal models for effects on interleukin release under inflammatory stimulation.
Why lipidation is used
Short hydrophilic peptides partition poorly into the stratum corneum, whose intercellular lipid lamellae favour lipophilic species. Attaching a sixteen-carbon palmitoyl chain shifts the partition coefficient substantially and also promotes self-assembly at interfaces. Permeation studies on this class generally report that lipidation improves penetration relative to the bare peptide, though absolute delivered fractions remain low and depend heavily on vehicle composition.
Typical study designs
Work with a formulated serum usually falls into two categories. In-vitro cell studies apply defined peptide concentrations to fibroblast monolayers or reconstructed skin equivalents and read out procollagen I, fibronectin, glycosaminoglycans or cytokine markers. Permeation studies use Franz diffusion cells with excised skin or synthetic membranes and quantify the peptide in receptor fluid and in tissue layers by LC-MS. Because the serum contains two actives, each should be quantified independently rather than as a combined figure.
Interpreting combination products
A two-peptide formulation cannot show which component drives an effect. Studies that intend to make mechanistic claims run single-peptide arms in the same vehicle alongside the combination, so that additivity, synergy or redundancy can actually be distinguished rather than assumed from the pairing.
